Structure Therapeutics Inc (GPCR)

2026-08-07T11:30:54.000Z - 12 days ago

Structure Therapeutics price target raised to $111 from $101 at Canaccord

2026-08-07T10:45:22.000Z - 12 days ago

Structure Therapeutics price target lowered to $97 from $100 at Citi

2026-08-07T10:16:46.000Z - 12 days ago

Structure Therapeutics price target lowered to $110 from $113 at Citizens

Aug 6, 2026, 4:00 PM EDT - 13 days ago

Structure Therapeutics Earnings release: Q2 2026

Aug 6, 2026, 4:00 PM EDT - 13 days ago

Structure Therapeutics Quarterly report: Q2 2026

Jun 17, 2026, 12:00 PM EDT - 2 months ago

Structure Therapeutics Transcript: AGM 2026

Jun 13, 2026, 2:00 PM EDT - 2 months ago

The Next Phase Of The Obesity Drug Race

LLY NVO

2026-06-11T10:06:10.000Z - 2 months ago

Structure Therapeutics price target lowered to $70 from $100 at H.C. Wainwright

Jun 9, 2026, 10:00 AM EDT - 2 months ago

Structure Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 5, 2026, 5:16 PM EDT - 2 months ago

Structure's experimental obesity pill shows no signs of liver injury

2026-06-05T20:10:53.000Z - 2 months ago

Structure Therapeutics announces ACCESS trial data published in Nature Medicine

Jun 5, 2026, 4:05 PM EDT - 2 months ago

Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity

Jun 5, 2026, 7:00 AM EDT - 2 months ago

Structure Therapeutics Slides: Corporate presentation

Jun 3, 2026, 12:15 PM EDT - 2 months ago

Structure Therapeutics Transcript: Jefferies Global Healthcare Conference 2026

May 26, 2026, 4:05 PM EDT - 3 months ago

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

May 7, 2026, 4:05 PM EDT - 3 months ago

Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

May 7, 2026, 4:00 PM EDT - 3 months ago

Structure Therapeutics Earnings release: Q1 2026

May 7, 2026, 4:00 PM EDT - 3 months ago

Structure Therapeutics Quarterly report: Q1 2026

Apr 27, 2026, 4:05 PM EDT - 4 months ago

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions

2026-04-27T12:58:41.000Z - 4 months ago

Canaccord starts Structure Therapeutics on oral weight loss pipeline

2026-04-27T10:00:27.000Z - 4 months ago

Structure Therapeutics initiated with a Buy at Canaccord

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Structure Therapeutics Proxy statement: Proxy filing

2026-04-14T20:17:51.000Z - 4 months ago

Structure Therapeutics appoints Matthew Lang as COO

Apr 14, 2026, 4:05 PM EDT - 4 months ago

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel

2026-03-16T15:55:34.000Z - 5 months ago

Structure Therapeutics price target lowered to $100 from $114 at H.C. Wainwright

2026-03-16T15:10:26.000Z - 5 months ago

Structure’s GLP-1 pill could put company on M&A radar, Barron’s says

LLY NVO

Mar 16, 2026, 10:46 AM EDT - 5 months ago

Weight Loss Pill from Structure Therapeutics Trimmed the Most Pounds Yet. Is the Biotech a Takeover Candidate?

Mar 16, 2026, 8:30 AM EDT - 5 months ago

Structure Therapeutics Transcript: Study result

Mar 16, 2026, 8:30 AM EDT - 5 months ago

Structure Therapeutics Press release: Study result

Mar 16, 2026, 8:30 AM EDT - 5 months ago

Structure Therapeutics Slides: Study result

2026-03-16T11:22:17.000Z - 5 months ago

Structure Therapeutics: Aleniglipron achieved meaningful weight loss in study

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

2026-03-02T11:26:56.000Z - 6 months ago

Structure Therapeutics price target raised to $114 from $90 at H.C. Wainwright

2026-02-27T10:55:51.000Z - 6 months ago

Structure Therapeutics price target lowered to $113 from $120 at Citizens

Feb 26, 2026, 4:02 PM EST - 6 months ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights

Feb 26, 2026, 4:00 PM EST - 6 months ago

Structure Therapeutics Annual report: Q4 2025

Feb 26, 2026, 4:00 PM EST - 6 months ago

Structure Therapeutics Earnings release: Q4 2025

Feb 3, 2026, 1:27 PM EST - 7 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN LLY NVO PFE VKTX

2026-01-30T15:51:54.000Z - 7 months ago

Structure Therapeutics emerges as top M&A target for big pharma, Axios says

2026-01-22T11:51:35.000Z - 7 months ago

Structure Therapeutics price target raised to $105 from $65 at JPMorgan

Jan 21, 2026, 10:05 AM EST - 7 months ago

Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s

2026-01-20T12:26:42.000Z - 7 months ago

Structure Therapeutics price target raised to $140 from $90 at Guggenheim

2026-01-19T22:30:27.000Z - 7 months ago

Structure Therapeutics moved to Buy rating at Goldman Sachs

LLY

Jan 15, 2026, 6:21 PM EST - 7 months ago

Structure CEO Ray Stevens talks its obesity drug portfolio

2026-01-14T18:05:20.000Z - 7 months ago

Novo Nordisk’s renewed M&A appetite sends obesity-drug names higher

LLY NVO PFE TERN VKTX

Jan 12, 2026, 7:00 AM EST - 7 months ago

Structure Therapeutics Slides: Corporate presentation

Dec 11, 2025, 4:01 PM EST - 8 months ago

Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional ADSs

Dec 9, 2025, 11:15 PM EST - 9 months ago

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants

Dec 8, 2025, 4:01 PM EST - 9 months ago

Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants

Dec 8, 2025, 11:20 AM EST - 9 months ago

Structure Therapeutics stock: what's driving sudden 103% jump in GPCR shares?

Dec 8, 2025, 8:30 AM EST - 9 months ago

Structure Therapeutics Transcript: Study Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

Structure Therapeutics Press release: Study Update

Dec 8, 2025, 8:30 AM EST - 9 months ago

Structure Therapeutics Slides: Study Update

Dec 8, 2025, 8:14 AM EST - 9 months ago

Structure's experimental pill shows 11% weight loss in study, shares up

Dec 8, 2025, 8:00 AM EST - 9 months ago

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Dec 7, 2025, 6:20 PM EST - 9 months ago

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

Nov 10, 2025, 6:21 PM EST - 10 months ago

Final Trade: UBER, CRWV, GPCR, DIS

CRWV UBER DIS

Nov 6, 2025, 4:01 PM EST - 10 months ago

Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nov 6, 2025, 4:00 PM EST - 10 months ago

Structure Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

Structure Therapeutics Earnings release: Q3 2025

Nov 5, 2025, 6:21 PM EST - 10 months ago

Fast Money: DAL, ROKU, AAPL, GPCR

AAPL ROKU DAL

Sep 10, 2025, 10:45 AM EDT - 1 year ago

Structure Therapeutics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 3, 2025, 3:55 PM EDT - 1 year ago

Structure Therapeutics Transcript: Cantor Global Healthcare Conference 2025

Aug 6, 2025, 4:01 PM EDT - 1 year ago

Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Structure Therapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Structure Therapeutics Earnings release: Q2 2025

Jun 23, 2025, 6:10 PM EDT - 1 year ago

Pharma companies need to beef up M&A right now, says Mizuho's Jared Holz

AMGN LLY NVO PFE REGN VKTX XBI

Jun 20, 2025, 7:30 PM EDT - 1 year ago

Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671

Jun 11, 2025, 10:40 AM EDT - 1 year ago

Structure Therapeutics Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 8, 2025, 4:00 PM EDT - 1 year ago

Structure Therapeutics Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Structure Therapeutics Quarterly report: Q1 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Structure Therapeutics Proxy statement: Proxy Filing

Mar 27, 2025, 7:40 AM EDT - 1 year ago

Biotech stocks have been hit hard. Why they're a great value now.

PFE BHVN DNLI INSM MRK SWTX

Mar 24, 2025, 6:26 PM EDT - 1 year ago

Structure Therapeutics CEO on latest GLP-1 developments

Mar 24, 2025, 6:23 PM EDT - 1 year ago

Final Trade: PYPL, UBER, NKE, GPCR

NKE PYPL UBER

Mar 10, 2025, 1:00 PM EDT - 1 year ago

Structure Therapeutics Transcript: Leerink Global Healthcare Conference 2025

Feb 27, 2025, 4:00 PM EST - 1 year ago

Structure Therapeutics Annual report: Q4 2024

Feb 27, 2025, 4:00 PM EST - 1 year ago

Structure Therapeutics Earnings release: Q4 2024

Feb 5, 2025, 10:30 AM EST - 1 year ago

Structure Therapeutics Transcript: Guggenheim SMID Cap Biotech Conference

Jan 30, 2025, 8:30 AM EST - 1 year ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

Dec 17, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Transcript: Study Update

Dec 17, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Press release: Study Update

Dec 17, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Slides: Study Update

Dec 17, 2024, 4:01 PM EST - 1 year ago

Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity

Dec 5, 2024, 6:17 PM EST - 1 year ago

Structure CEO on the competitive landscape for oral GLP-1 drugs

NVO

Nov 20, 2024, 3:00 AM EST - 1 year ago

Structure Therapeutics Transcript: Jefferies London Healthcare Conference 2024

Nov 15, 2024, 8:30 AM EST - 1 year ago

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Nov 13, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Transcript: Study Update

Nov 13, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Press release: Study Update

Nov 13, 2024, 4:30 PM EST - 1 year ago

Structure Therapeutics Slides: Study Update

Nov 13, 2024, 4:01 PM EST - 1 year ago

Structure Therapeutics Announces First Patients Dosed in Phase 2b ACCESS Clinical Study Evaluating Oral Small Molecule GLP-1 Receptor Agonist, GSBR-1290, for Obesity

Nov 13, 2024, 4:00 PM EST - 1 year ago

Structure Therapeutics Quarterly report: Q3 2024

Nov 13, 2024, 4:00 PM EST - 1 year ago

Structure Therapeutics Earnings release: Q3 2024

Sep 19, 2024, 9:10 AM EDT - 2 years ago

Structure Therapeutics Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 17, 2024, 4:05 PM EDT - 2 years ago

Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D.

Sep 5, 2024, 10:00 AM EDT - 2 years ago

Structure Therapeutics Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 27, 2024, 4:05 PM EDT - 2 years ago

Structure Therapeutics Appoints Angus C. Russell to Board of Directors

Aug 26, 2024, 12:00 PM EDT - 2 years ago

Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say

AMGN CRBP SRRK VKTX

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Structure Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 4:00 PM EDT - 2 years ago

Structure Therapeutics Earnings release: Q2 2024

Jun 11, 2024, 6:37 PM EDT - 2 years ago

Structure Therapeutics CEO on GLP drugs

Jun 7, 2024, 4:05 PM EDT - 2 years ago

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares

Jun 5, 2024, 7:53 PM EDT - 2 years ago

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

Jun 3, 2024, 6:27 PM EDT - 2 years ago

Structure Therapeutics is a 'no-brainer takeout' target, says Mizuho's Jared Holz

Jun 3, 2024, 4:09 PM EDT - 2 years ago

Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants

Jun 3, 2024, 2:38 PM EDT - 2 years ago

Structure Therapeutics reports promising weight-loss drug data

Jun 3, 2024, 8:42 AM EDT - 2 years ago

Structure Therapeutics' stock jumps on weight-loss-pill trial results

Jun 3, 2024, 8:30 AM EDT - 2 years ago

Structure Therapeutics Transcript: Study Update

Jun 3, 2024, 8:30 AM EDT - 2 years ago

Structure Therapeutics Press release: Study Update

Jun 3, 2024, 8:30 AM EDT - 2 years ago

Structure Therapeutics Slides: Study Update

Jun 3, 2024, 8:00 AM EDT - 2 years ago

Structure Therapeutics Registration statement: Registration Filing

Jun 3, 2024, 7:30 AM EDT - 2 years ago

Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290

May 9, 2024, 4:00 PM EDT - 2 years ago

Structure Therapeutics Quarterly report: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Structure Therapeutics Earnings release: Q1 2024

May 7, 2024, 11:33 AM EDT - 2 years ago

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

AMGN LLY NVO ALT AZN VKTX

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Structure Therapeutics Proxy statement: Proxy Filing

Apr 16, 2024, 7:09 PM EDT - 2 years ago

Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.

AMGN AZN LLY NVO PFE SNY VKTX

Mar 13, 2024, 8:00 AM EDT - 2 years ago

Structure Therapeutics Transcript: Leerink Partners Global Biopharma Conference 2024

Mar 9, 2024, 2:30 AM EST - 2 years ago

Wegovy and Zepbound Are King. Who's Coming for Their Crowns.

NVO PFE VKTX

Mar 8, 2024, 4:05 PM EST - 2 years ago

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Mar 8, 2024, 8:30 AM EST - 2 years ago

Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights